PapersPMID:23343189
Meta-analysis of randomized controlled trials on magnesium in addition to beta-blocker for prevention of postoperative atrial arrhythmias after coronary artery bypass grafting.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“Overall mortality was not significantly affected by magnesium in addition to beta-blocker (OR 0.59, 95% CI 0.08-4.56, P = 0.62).”
- Study
- meta-analysis
- Effect
- 0.59 odds ratio, 95% CI 0.08 to 4.56
- Dose studied
- IV bolus or continuous infusion, total dose beyond 35 mmol, given prophylactically before onset of arrhythmia; pooled across 5 trials with varying regimens
- Population
- Adults undergoing coronary artery bypass grafting in sinus rhythm preoperatively, given magnesium in addition to beta-blocker versus beta-blocker alone (beta-blocker constant background in both arms); postoperative mortality, 3 trials, 454 patients
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults undergoing coronary artery bypass grafting (on-pump or off-pump), in sinus rhythm at the time of surgery; 5 RCTs, 1,251 patients, magnesium given in addition to beta-blocker versus the same type of beta-blocker alone
- Participants
- 1,251
- Comparator
- an active treatment / placebo
- Duration
- not reported
- Endpoints measured
- 4
magnesium(2+)